Literature DB >> 24426497

Retroperitoneal peripheral nerve sheath tumour of triton type-a case report.

Dakshyani S Nirhale1, Amit Parasnis1, Charit Bora1, Ruchita Gupta1, Prabhjot Aulakh1.   

Abstract

The malignant peripheral nerve sheath tumour is the malignant counterpart to benign soft tissue tumours such as neurofibromas and schwannomas. Malignant Triton Tumour is a histological variant of malignant peripheral nerve sheath tumours with rhabdomyosarcomatous differentiation. They are known to develop in cases of neurofibromatosis type 1 (von Recklinghausen's disease). Malignant peripheral nerve sheath tumor is biologically an aggressive tumour for which the treatment of choice is surgery. Here we report a rare case of malignant peripheral nerve sheath tumour, not associated with neurofibromatosis type 1 and arising in the retroperitoneum.

Entities:  

Keywords:  Malignant triton tumour; Neurofibromatosis; Peripheral nerve sheath tumour

Year:  2011        PMID: 24426497      PMCID: PMC3693317          DOI: 10.1007/s12262-011-0300-z

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  8 in total

1.  Malignant "Triton" tumor of the posterior mediastinum: prolonged survival after staged resection.

Authors:  Loïc Lang-Lazdunski; François Pons; René Jancovici
Journal:  Ann Thorac Surg       Date:  2003-05       Impact factor: 4.330

Review 2.  Postradiation malignant triton tumor. A case report and review of the literature.

Authors:  R Yakulis; L Manack; A I Murphy
Journal:  Arch Pathol Lab Med       Date:  1996-06       Impact factor: 5.534

3.  A huge malignant triton tumour.

Authors:  Badar Murtaza; Zafar Iqbal Gondal; Arshad Mehmood; Shahzad Saleem Shah; Muhammad Hanif Abbasi; Muhammad Sarmad Tamimy; Syed Tahawwar Mujtaba Kazmi
Journal:  J Coll Physicians Surg Pak       Date:  2005-11       Impact factor: 0.711

4.  Recurrent malignant Triton tumour: first report on a long time survivor.

Authors:  Wolfgang J Köstler; Gabriele Amann; Thomas W Grunt; Christian F Singer; Sonja M Schneider; Thomas Brodowicz; Sandra Tomek; Christoph C Zielinski
Journal:  Oncol Rep       Date:  2003 May-Jun       Impact factor: 3.906

5.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Authors:  B S Ducatman; B W Scheithauer; D G Piepgras; H M Reiman; D M Ilstrup
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

6.  Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors).

Authors:  J M Woodruff; N L Chernik; M C Smith; W B Millett; F W Foote
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

Review 7.  Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor).

Authors:  Christopher J Stasik; Ossama Tawfik
Journal:  Arch Pathol Lab Med       Date:  2006-12       Impact factor: 5.534

8.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases.

Authors:  J E Wanebo; J M Malik; S R VandenBerg; H J Wanebo; N Driesen; J A Persing
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

  8 in total
  4 in total

1.  Retroperitoneal Malignant Peripheral Nerve Sheath Tumour: A Rare Case Report.

Authors:  Ayse Nur Deger; Mehmet Akif Bayar; Muzaffer Caydere; Hakki Deger; Mahir Tayfur
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Malignant Triton Tumors in Sisters with Clinical Neurofibromatosis Type 1.

Authors:  Basnet Alina; Jofre A Sebastian; Capo Gerardo
Journal:  Case Rep Oncol Med       Date:  2015-05-31

3.  Intrapelvic malignant nerve sheath tumors presenting as acute urinary retention: A case report and literature review.

Authors:  Ali Ariafar; Faisal Ahmed; Seyed Hossein Hosseini; AbdolAzim Khorshidi; Simin Torabi-Nezhad
Journal:  Clin Case Rep       Date:  2022-08-18

4.  Preoperative management of giant retroperitoneal schwannoma: A case report and review of the literature.

Authors:  Wei Chen; Chengxue Dang; Kun Zhu; Kang Li
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.